Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9854151 | 0.88 | CHRM5 (0.34) | TSHRCHRM5CHRM1CHRM3GALR3 | |
| SCHEMBL64443 | 0.81 | TSHR (0.34) | TSHRALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL9854168 | 0.78 | TSHR (0.35) | TSHRALDH1A1 | |
| SCHEMBL7456092 | 0.77 | TSHR (0.39) | TSHRALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL251951 | 0.77 | ALDH1A1 (0.60) | TSHRALDH1A1 | |
| SCHEMBL9186445 | 0.76 | TSHR (0.37) | TSHRALDH1A1 | |
| SCHEMBL241532 | 0.75 | CHRM5 (0.34) | TSHRCHRM5CHRM1CHRM3GALR3 | |
| SCHEMBL9056348 | 0.75 | TSHR (0.62) | TSHRALDH1A1 | |
| SCHEMBL1171604 | 0.75 | TSHR (0.42) | TSHRALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL446081 | 0.75 | TSHR (0.38) | TSHRALDH1A1CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12619104-B2 | Method of manufacturing a contact lens | PEGAVISION CORPORATION (TW) | 2026-05-05 | — | — | US | disclosed |
| US-20260118702-A1 | METHOD OF MANUFACTURING CONTACT LENS | PEGAVISION CORP (TW) | 2026-04-30 | — | — | US | disclosed |
| US-12541120-B2 | Contact lens and method of manufacturing the same | PEGAVISION CORPORATION (TW) | 2026-02-03 | — | — | US | disclosed |
| EP-4653479-A1 | ETHYLENE/ALPHA-OLEFIN COPOLYMER FOR SOLAR CELL ENCAPSULATION ADHESIVE FILM, AND USE THEREOF | Wanhua Chemical Group Co., Ltd. (CN) | 2025-11-26 | — | — | EP | disclosed |
| US-12371561-B2 | Thermoplastic vulcanizate material, article formed by the same and method for forming the same | LCY Chemical Corp. (TW) | 2025-07-29 | — | — | US | disclosed |
| US-20240085726-A1 | METHOD OF MANUFACTURING A CONTACT LENS | PEGAVISION CORPORATION (TW) | 2024-03-14 | — | — | US | disclosed |
| EP-4171582-B1 | POLYMER MEDICAMENT FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF | WATERSTONE PHARMACEUTICALS WUHAN CO LTD (CN) | 2024-03-13 | — | — | EP | disclosed |
| EP-4171582-A1 | POLYMER MEDICAMENT FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. (CN) | 2023-05-03 | — | — | EP | disclosed |
| US-20230102317-A1 | POLYMER MEDICAMENT FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF | WATERSTONE PHARMACEUTICALS (WUHAN) CO., LTD. (CN) | 2023-03-30 | — | — | US | disclosed |
| WO-2023035274-A1 | POLYMER MEDICAMENT FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF | WATERSTONE PHARMACEUTICALS(WUHAN) CO., LTD. (CN) | 2023-03-16 | — | — | WO | disclosed |
| US-8728628-B2 | Passivant for hot-dip Al-Zn-coated sheet and preparation method and use thereof | Pangang Group Steel Vanadium and Titanium Co., Ltd. (CN) | 2014-05-20 | — | — | US | disclosed |
| CN-103205146-A | Ultraviolet-curable PET film surface treatment bottom sizing agent and preparing method and application thereof | GUANGZHOU INST GEOCHEM CAS | 2013-07-17 | — | — | CN | disclosed |
| CN-102898734-A | Polystyrene resin composition and preparation method thereof | PETROCHINA CO LTD | 2013-01-30 | — | — | CN | disclosed |
| CN-102608069-A | Method for preparing chlorsulfuron molecular imprinting SPR (surface palsmon resonance) sensor chip | INST AGRICULTURAL QUALITY STANDARD & INSPECTION TECHNOLOGY CHINA ACADEMY AGRICULTURAL SCI | 2012-07-25 | — | — | CN | disclosed |
| US-20120135267-A1 | PASSIVANT FOR HOT-DIP AL-ZN-COATED SHEET AND PREPARATION METHOD AND USE THEREOF | PANGANG GROUP RESEARCH INSITUTE CO., LTD. (CN) | 2012-05-31 | — | — | US | disclosed |
| US-20100020274-A1 | COLORANT, COLOR FILTER, LCD DEVICE, COMPOSITION AND METHOD FOR PREPARING THE SAME | BOE TECHNOLOGY GROUP CO.,LTD (CN) | 2010-01-28 | — | — | US | disclosed |
| EP-0430611-A2 | Pigmented particles | NIPPON PAINT CO., LTD. (JP) | 1991-06-05 | — | — | EP | disclosed |
| EP-0314158-A2 | Resin particles | Nippon Paint Co., Ltd. (JP) | 1989-05-03 | — | — | EP | disclosed |
| EP-0275899-A2 | Process for preparing particles having monodisperse particle size | Nippon Paint Co., Ltd. (JP) | 1988-07-27 | — | — | EP | disclosed |
| EP-0251228-A2 | Photosensitive flexographic printing plate | Nippon Paint Co., Ltd. (JP) | 1988-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12541120-B2 | Contact lens and method of manufacturing the same | IK, PDCD2L, ORAI1 | TSHR 591/4885ALDH1A1 4594/4885CHRM5 1302/4885 |
| US-12619104-B2 | Method of manufacturing a contact lens | ORAI1, CASR, KCNN1 | TSHR 346/4885ALDH1A1 4572/4885CHRM5 1284/4885 |
| US-20260118702-A1 | METHOD OF MANUFACTURING CONTACT LENS | CRYAB, CRYAA, CRYZ | TSHR 285/4885ALDH1A1 3576/4885CHRM5 1307/4885 |
| US-20230102317-A1 | POLYMER MEDICAMENT FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF | OXSR1, PHYKPL, BRSK2 | TSHR 1123/4885ALDH1A1 3755/4885CHRM5 2207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.